MarketResearchReports.Biz
announces addition of new report"
Gastrointestinal Stromal Tumor (GIST) Global Clinical Trials Review,
H1, 2016 "to
its database.
GlobalData's
clinical trial report,
Gastrointestinal Stromal Tumor (GIST)
Global Clinical Trials Review, H1, 2016" provides an overview of
Gastrointestinal Stromal Tumor (GIST) clinical trials scenario. This
report provides top line data relating to the clinical trials on
Gastrointestinal Stromal Tumor (GIST). Report includes an overview of
trial numbers and their average enrollment in top countries conducted
across the globe. The report offers coverage of disease clinical
trials by region, country (G7 & E7), phase, trial status, end
points status and sponsor type. Report also provides prominent drugs
for in-progress trials (based on number of ongoing trials).
GlobalData Clinical Trial Reports are generated using GlobalDatas
proprietary database - Pharma eTrack Clinical trials database.
Clinical trials are collated from 80+ different clinical trial
registries, conferences, journals, news etc across the globe.
Clinical trials database undergoes periodic update by dynamic
process.
The
report enhances the decision making capabilities and helps to create
an effective counter strategies to gain competitive advantage.
Download Sample copy of this
Report at
Scope
-
The report provides a snapshot of the global clinical trials
landscape
-
Report provides top level data related to the clinical trials by
Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor
Type and End point status
-
The report reviews top companies involved and enlists all trials
(Trial title, Phase, and Status) pertaining to the company
-
The report provides all the unaccomplished trials (Terminated,
Suspended and Withdrawn) with reason for unaccomplishment
-
The Report provides enrollment trends for the past five years
-
Report provides latest news for the past three months
Reasons to buy
-
Assists in formulating key business strategies with regards to
investment
-
Helps in identifying prominent locations for conducting clinical
trials which saves time and cost
-
Provides top level analysis of Global Clinical Trials Market which
helps in identifying key business opportunities
-
Supports understanding of trials count and enrollment trends by
country in global therapeutics market
-
Aids in interpreting the success rates of clinical trials by
providing a comparative scenario of completed and uncompleted
(terminated, suspended or withdrawn) trials
-
Facilitates clinical trial assessment of the indication on a global,
regional and country level
Follow us on LinkedIn:
https://www.linkedin.com/company/marketresearchreports-biz
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average
Enrollment by Country 7
Top Five Countries Contributing
to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing
to Clinical Trials in Europe 11
Top Countries Contributing to
Clinical Trials in North America 12
Top Five Countries Contributing
to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing
to Clinical Trials in Central and South America 14
Clinical Trials by G7
Countries: Proportion of Gastrointestinal Stromal Tumor (GIST) to
Oncology Clinical Trials 15
Clinical Trials by Phase in G7
Countries 16
Clinical Trials in G7 Countries
by Trial Status 17
Clinical Trials by E7
Countries: Proportion of Gastrointestinal Stromal Tumor (GIST) to
Oncology Clinical Trials 18
Clinical Trials by Phase in E7
Countries 19
Clinical Trials in E7 Countries
by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status
23
Clinical Trials by End Point
Status 24
Subjects Recruited Over a
Period of Time 25
Clinical Trials by Sponsor Type
26
Prominent Sponsors 27
Top Companies Participating in
Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials 28
Prominent Drugs 30
Latest Clinical Trials News on
Gastrointestinal Stromal Tumor (GIST) 31
May 24, 2016: Arog
Pharmaceuticals Presents Crenolanib Clinical Data at the 2016
American Society of Clinical Oncology Annual Meeting 31
Apr 20, 2016: Kolltan
Pharmaceuticals Announces Presentations of Anti-KIT Antibody
Preclinical Data at the 2016 American Association for Cancer Research
Annual Meeting 31
Clinical Trial Profile
Snapshots 33
Appendix 299
Abbreviations 299
Definitions 299
Research Methodology 300
Secondary Research 300
About GlobalData 301
Contact Us 301
Disclaimer 301
Source 301
About us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment